JunAP
Latest Information Update: 29 Apr 2024
At a glance
- Originator Sapience Therapeutics
- Class Antineoplastics; Peptides
- Mechanism of Action Transcription factor AP-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Haematological malignancies; Solid tumours